Sandoz

Jul 07, 2020

Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals

Mar 23, 2020

Sandoz acquires US distribution rights to two key hospital injectable medicines, reinforcing strategic focus on key growth segment

Jun 27, 2019

Sandoz enters agreement with Kit Check to track, automate restocking of products in U.S. hospitals

Feb 19, 2019

Sandoz Inc. launches authorized generic version of buprenorphine and naloxone sublingual film

Jul 06, 2018

Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure Requirements

Feb 13, 2018

Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis

Jan 26, 2018

CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)

Jan 16, 2018

Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA

Dec 08, 2017

Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine

Oct 04, 2017

FDA Approval of Mylan's Glatiramer Acetate Will Turn the Payer Pressure On for Teva's Copaxone and Sandoz's Glatopa

Sep 12, 2017

Sandoz proposed biosimilar rituximab accepted for review by the FDA